Идеально, что, помимо обычных специалистов обратитесь к психотерапевтам, дополнительные, альтернативные или комплексные, поскольку они используют методы terapeúticas признанной эффективности лечение и профилактика дегенеративных заболеваний токсичных и в питании, как СПИД (124-141,w-z).
СДЕЛАТЬ ЭТО В ПОДХОДЯЩИЙ МОМЕНТ
8.1. Лечение и профилактика СПИДа, как синдром токсического и питания может только быть эффективным, если:
а) человек или сообщество не имеют ни малейшего сомнения, что то, что он делает это правильно, ибо понимают, в подробностях, что СПИД-это синдром дегенеративные токсичен и питания, вызванных выставок недобровольным исчезновениям и иногда добровольные, множественные, повторяющиеся и хронических стрессовых агентов иммунологические, которые вызывают состояния опьянения или окисления система ISBN и других систем организма. Идеально подходит, что родственники и близких друзей, понять это, и
б) лечения и профилактики были направлены специалисты здоровья или врачи, которые также разделяют целиком и полностью, что СПИД-это синдром токсического и рационального питания, можно предотвратить, вылечить и erradicable и что они намерены и могут сделать. Предпочтение лицам, которые имеют широкое видение и глобальной традиционной медицины и лекарств альтернативных или дополнительных.
8.2. Часто возникают дискуссии между люди, “ВИЧ-инфицированные” и больными, с работниками здравоохранения или врачи, которые считают, что СПИД-это заболевание, которое вирус, называемый “ВИЧ”. В случае, если это случилось, следует избегать столкновений радикалов, которые приносят наибольшее беспокойство и депрессии людей “ВИЧ-инфицированных” и больных (47-53).
|
|
8.3. Если болен СПИДом или человек, который реагирует положительно на зло называемых “тестов на ВИЧ” изучив всю доступную информацию (228-230), вы решили изменить так называемых антиретровирусных препаратов по альтернативной терапии и не токсичен, это должна производиться постепенно и прогрессивно, так как ингибиторы протеазы которые входят в состав “коктейлей” имеют действия антиоксидантов (231) и подвесить на резко может создать деликатные ситуации стресса окислительного и иммуносупрессии.
Некоторые сайты Интернет-ссылки на научные споры по проблемам причины и способы решения проблемы СПИДа:
www.robertogiraldo.com
www.duesberg.com
www.theperthgroup.com
www.virusmyth.com
www.rethinkingaids.com
www.toxi-health.com
www.aidsmyth.com
www.aliveandwell.org
www.healaids.com
www.healtoronto.com
www.amcmh.org
www.vivoysano.com
ССЫЛКИ
1. ХИРАЛЬДО РА. Научной полемики Международный о причине СПИДа. Исследования и Обучения среднего медицинского персонала (Университет Антиокия Медельин, Колумбия) 1996; 14(2): 55-74.
2. ХИРАЛЬДО РА. Роль стрессовых иммунологические в иммунодефицита. IATREIA (Университет Антиохии, Факультет Медицины, Медельин, Колумбия) 1997; 10:62-76.
3. ХИРАЛЬДО РА. Тревожный рост числа глобальных агентов, вызывающих стресс иммунологический. В: КОПЧЕНОЕ C, ЭРНАНДЕС-В, ВЕЛАСКО М. международные Отношения, социальная политика и здоровье: проблемы в эпоху глобализации. Докладов международного форума. Богота, Колумбия: Фонд Культуры Ксавьера Изобразительного Искусства; 1998: 49-73.
4. ХИРАЛЬДО РА. Агенты стрессовых иммунологические являются истинной причиной СПИДа. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 82-123.
|
|
5. DUESBER PH. Retroviruses as carcinogens and болезнетворные микроорганизмы: expectations and reality. Рак Research, 1987;
6. DUESBERG PH. AIDS acquired by drug consumption and other non-contagious risk factors. Pharmac Термо 1992; 55:201-277.
7. DUESBERG PH, RASNICK D. The drug-AIDS hypothesis. Континуум (London) 1997; 4(5): S1-S24.
8. DUESBERG PH, RASNICK D. The AIDS дилемма: Drug diseases blamed on a passenger вирусов. G enetica 1998; 104: 85-132.
9. PAPADOPULOS-ELEOPULOS E. Reappraisal of AIDS - Is the oxidation induced by the risk factors the primary cause? Medical Hypothesis 1988; 25:151-162.
10. PAPADOPULOS-ELEOPULOS, E, ТЕРНЕР V & PAPADIMITRIOU J. Oxidative stress, HIV and AIDS. Immunol Res 1992; 143:145-148.
11. PAPADOPULOS-ELEOPULOS E. Looking back on the oxidative stress theory of AIDS. Континуум (London) 1998-1999; 5(5): 30-35
12. ХИРАЛЬДО РА. Свободные радикалы и иммунодефицита. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 33-36.
13. FAVIER A. The place of oxygen free-радикалов in HIV infection. A collection of papers presented at a conference on “The place of oxygen free-радикалов in HIV infection”, Les Deux Alpex, France, January 1993. Chemico-Biological Inter a ctions 1994; 91: 77-224.
14. PIETTE et al. Molecular mechanisms of virus activation by free-радикалов. Collection of 5 articles presented at a conference on “The place of oxygen free-радикалов in HIV infection” Les Deux Alpes, France, January 1993. Chemico-Biological Interactions 1994; 91: 79-132.
15. FAVIER et al. Газов $ + хроматографи status and lipid peroxidation in patients infected with HIV. Chemico-Biological Interactions 1994; 91: 165-180.
16. FUCHS J et al. Oxidative imbalance in HIV infected patients. Med Hypothesis 1991; 36: 60-64.
17. JARSTRAND C, B. AKERLUND Oxygen radical release by neutrophils of HIV-infected patients. Chemico-Biological Interactions 1994; 91: 141-146.
18. ЛЭЙСИ CJ et al. Газов $ + хроматографи-micronutrients and HIV infection. International J STD & AIDS 1996; 7: 485-489.
19. PASSI S. Progressive increase of oxidative stress in advanced human bdy. Континуум (London) 1998; 5(4): 20-26.
20. ХАВЬЕР JJ et al. Газов $ + хроматографи micronutrients and immune function in HIV-1 infection. FASEB Proc 1990; 4A: 940-945.
21. АЛЛАР VP et al. Oxidative stress and plasma газов $ + хроматографи micronutrients in humans with HIV infection. Am J Clin Nutr 1998; 67: 143-147.
|
|
22. REVILLARD JP, FAVIER AE, ZITTOUN МИКЕЛЕ. Lipid peroxidation in human bdy virus infection. J AIDS 1992; 5: 637-638.
23. SALVAIN B, MARK AW. The role of oxidative stress in disease progression in individuals infected by the human bdy вирус. J Leukocyte Biol 1992; 52: 111.
24. BARUCHEL S, WAINBERG МА. The role of oxidative stress in disease progression in individuals infected by the human bdy вирус. J Leukocyte Biol 1992; 51: 111-114.
25. CONSTANS J et al. Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and многотомное статус. Clinical Biochemistry 1995; 28: 421-426.
26. ПОЛЯКОВ VM et al. Superoxide анион production and enzymatic дисбаланс in peripheral blood cells isolated from HIV-infected children. Free Radic Biol Med 1994; 16: 15-21.
27. HOMMES MJT et al. Resting energy expenditure and substrate oxidation in human bdy вирусов (ВИЧ)-infected asymptomatic men: HIV affects узла metabolism in the early asymptomatic stage. Am J Clin Nutr 1991; 54: 311-315.
28. SHALLENBERGER Ф. Selective compartmental доминирование: An explanation for a nonifectious, многофакторной выходные данные for acquired immune deficiency syndrome (AIDS), and a rationale for ozone therapy and other immune modulating therapies. Med Hypothesis 1998; 50:67-80.
29. STAAL FJT et al. Antioxidants запрета stimulation of HIV transcription. AIDS Res Hum Retroviruses 1993; 9: 299-306.
30. ДВОРКИН МОДЕЛЬ, РОЗЕНТАЛЬ ВТ, УОРМСЕР G, WEISS L. Selenium deficiency in the acquired immuno-deficiency syndrome). J Парентерального Enteral Nutr 1986; 10: 405.
31. ДВОРКИН МОДЕЛЬ. Selenium deficiency in HIV infection and the aquired bdy syndrome (AIDS). Chemico-Biological Interactions 1994; 91: 181-186.
32. CIRELLI et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991; 24: 211-214.
33. SCHRAUZER GN, SACHER J. Selenium in the maintenance and therapy of HIV-infected patients. Chem Biol Inter 1994; 91: 199.
34. SIMON G et al. Effects of глутатиона precursors on гуманитарных bdy virus replication. Chemico-Biological Interactions 1994; 91: 217-224.
35. STAAL FJT et al. Intracellular глутатиона levels in T-cells подмножествах decrease in the blood plasma of HIV-1 infected patients. Biol Chem Хоппе Сейлер 1989; 370: 101-108.
36. БУЛЬ R et al. Systemic glutathion deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; ii: 1294-1298.
37. DORGE ВТ, ЭК HL, MIHM S. HIV-induced цистеин deficiency and T-cell выходные данные: a rationale for treatment with n-acetyl-cysteine. Immunol Today 1992; 13: 211.
38. PASSI S et al. Study on plasma polyunsaturated fatty acids and vitamin E, and on erythrocyte glutathion peroxidase in highrisk HIV infection categories and AIDS patients. Clin Chem Enzym Comns 1993; 5: 169-177.
39. QUEY B et al. Глутатион-depletion in HIV-infected patients: role of cysteine deficiency and effect of oral n-acetyl-cysteine. AIDS 1992; 5: 814.
40. KALEVIC T et al. Suppression of human bdy вирус expression in библиогр. в конце гл infected monocytic cells by глутатион, глутатион Эстер и N-acetyl-cysteine. Proc Natl Acad Sci U. S. A. 1991; 88: 986
41. FABRIS N et al. AIDS, zinc deficiency and thymic hormone failure. JAMA 1988; 259: 839.
42. WALTER R et al. Цинк status in human bdy virus infection. Life Sci 1990; 47: 1579 году.
43. FALUTZ J et al. Цинк as a определителей in HIV-induced immunosuppression. JAMA 1988; 259: 2850-2851.
44. ГРЭМ N et al. Relationship of serum Купер and zinc levels to HIV-1 seropositivity and progression to AIDS. JAIDS 1991; 4: 976-980.
45. ХИРАЛЬДО РА. AIDS and Stressors: AIDS in Neither an Infectious Disease nor is Sexually Transmitted. It is a Toxic-Пищевая Syndrome Caused by the Alarming Worldwide Increment of Многотомное Stressor Agents. Медельин Заглавие: Печатные Begón, 1997: 205.
46. ХИРАЛЬДО РА. Истинный смысл быть “ВИЧ-положительный”. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 109-112.
47. KIECOLT-GLASER JK, GLASER R. Psychological influences on immunity. Implications for AIDS. Amer J Психологию 1988; 43: 892-899.
48. KEMENY МЕНЯ. Psychoneuroimmunology of HIV infection. В: ZEGANS LS КОУТС TJ. Psychiatric manifestations of HIV disease. Psychiat Clin N Am 1994; 17: 55 -68.
49. PERRY S. Psychoneuroimmunology and AIDS: challenge или “Челленджер”? В: STEIN M, BAUM A. Perspectives in behavioral medicine: chronic diseases. Secaucus Meadowlands, NJ: Lawrence Erlbaum Associated Publishers; 1995: 273-286.
50. КОУЛ SW, KEMENY МЕНЯ. Psychosocial influences on the progression of HIV infection. В: ГАДЮКА R, FELTEN DL, COHEN N. Psychoneuroimmunology. 3a ed. San Diego: Academic Press; 2001: 583-612.
51. ADDER R, FELTEN DL, COHEN N. Psychoneuroimmunology. 3a ed. San Diego: Academic Press; 2001: Vol 1: 727p, Том 2: 856p.
52. FRIEDMAN H, BENDINELLI M, SPECTER S. Psychoneuroimmunology, stress and infections. Nueva York: Plenum Press; 1995: 300.
53. KEMENY ME et al. Psychoneuroimmunology. En: NEMEROFF C. Neuroendocrinology. Telford, NJ: Telford Press; 1992: 563-591.
54. GIRALDO RA. Propuesta para la patogénesis y la historia natural del sida. En: Sida y agentes estresantes. Medellín, Colombia: Editorial Universidad de Antioquia; 2002: 47-71.
55. KIMBER I, SELGRADE MJK. T lymphocyte subpopulations in immunotoxicology. Chichester: John Wiley & Sons; 1998: 302.
56. BREEN C, GOLIGHTLY M. Immunodeficiency. In: LEHMANN CA. Saunders manual of clinical laboratory science. Philasdelphia: W.B. Saunders Company; 1998; 307-324.
57. ROSE NR, HAMILTON RG, DETRICK B. Manual of clinical laboratory immunology. 6a ed. Washington: ASM Press; 2002: 1322.
58. BEACH RS, LAURA PF. Nutrition and the acquired immunodeficiency syndrome. Ann Intern Med 1983; 99: 565-566.
59. CHELLURI L, JASTREMSKI MS. Insidence of malnutrition in patients with acquired immunodeficiency syndrome. Nutr Clin Pract 1989; 4: 16 -18.
60. CHLEBOWSKI RT. Significance of altered nutritional status in acquired immune deficiency syndrome (AIDS). Nutr Cancer 1985; 7: 85-91.
61. COODLEY GO. Nutritional deficiency and AIDS. Ann Intern Med 1990; 113: 809.
62. GRAY RH. Similarities between AIDS and protein calorie malnutrition (PCM). AJPH 1983; 73: 1332
63. JAIN VK, CHANDRA RK. Does nutritional deficiency predispose to AIDS? Nutr Res 1984; 4: 537-542.
64. KEUSCH GT, FARTHING MJG. Nutritional aspects of AIDS. Annu Rev Nutr 1990; 10: 475-501.
65. KEUSCH GT, THEA DM. Malnutrition in AIDS. Medical Clinics of North America: Clinical Nutrition 1993; 77: 795-814.
66. KOTLER DP et al. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985; 42: 1255-1265.
67. ABRAMS B et al. A prospective study of dietary intake and acquired immunodeficiency syndrome in HIV-seropositive homosexual men. J AIDS 1993; 6: 949-958.
68. BAUM MK et al. Micronutrients and HIV-1 disease progression. AIDS; 1995; 9: 1051-1056.
69. BEACH RS et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6: 701-708.
70. MELCHIOR JC et al. Resting energy expenditure is increased in stable malnourished HIV-infected patients. Am J Clin Nutr 1991; 53: 437-441.
71. PERIQUET BA et al. Micronutrient levels in HIV-1 infected children. AIDS 1995; 9: 887-893.
72. MOSESON M et al. The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. JAIDS 1989; 2: 235-247.
73. SKURNICK JH, et al. Micronutrients profiles in HIV-1-infected heterosexual adults. J Acq Immundef Syndr Hum Retrov 1996; 12: 75-83.
74. TANG AM et al. Dietary micronutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993; 138: 1- 15.
75. TANG AM et al. Effects of micronutrients intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996; 143: 1244- 1256.
76. BOGDEN JD et al. Micronutrients status and human immunodeficiency virus (HIV) infection. Ann NY Acad Sci 1990; 547: 189-195.
77. COODLEY GO et al. Micronutrient concentrations in the HIV wasting syndrome. AIDS 1993; 7: 1595-1600.
78. KEHRER JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21 -48.
79. REID L. Oxidative stress and antioxidants. A nutritional perspective. Continuum (London) 1998; 5(3): 52-54.
80. SLATER TF. Free radicals: formation, detection, reactivity, and citoxicity. En: LACHMAN PJ, PETERS SK, ROSEN FS, WALPORT MJ. Clinical aspects of immunology. Boston: Blackwell Scientific Publications; 1993: 377-393.
81. SIMIC MG. DNA markers of oxidative processes in vivo: relevance to carcinogenesis and anticarcinogenesis. Cancer Res (Suppl) 1994; 54: 1918s.
82. JOVANOVIC S. Biomarkers of oxidative stress in clinical practice. Townsend Letter for Doctors and Patients 1998; August/September: 72-76.
83. ARMSTRONG D. Oxitadive stress biomarkers and antioxidant protocols. Totowa, NJ; 2002: 322.
84. PAPADOPULOS-ELEOPULOS E, TURNER V & PAPADIMITRIOU JM. Is a positive Western blot proof of HIV infection? Bio/Technology 1993; 11:696-707.
85. PAPADOPULOS-ELEOPULOS E, TURNER V, PAPADIMITRIOU J & CAUSER D. HIV Antibodies: further questions and a plea for clarification. Curr Med Res Opin 1997; 13: 627-634.
86. TURNER VF. Do HIV Antibody tests prove HIV infection? Continuum (London) 1996; 3:8-11.
87. TURNER VF. Do antibody tests prove HIV infection?. Interview by Huw Christie editor of Continuum. Continuum (London) Winter 1997/8; 5(2): 10-19.
88. GIRALDO RA. Las pruebas de ELISA, Western blot y carga viral usadas en el diagnóstico de la “infección VIH” no son adecuadas. En: Sida y agentes estresantes. Medellín, Colombia: Editorial Universidad de Antioquia; 2002: 87-92.
89. GIRALDO RA. Ser “VIH positivo” o “seropositivo” no indica estar infectado con el “VIH”. En: Sida y agentes estresantes. Medellín, Colombia: Editorial Universidad de Antioquia; 2002: 92-95.
90. CHRISTIE H. CONTINUUM. HIV Positive? - It depends where you live. Take a look at the criteria that determine a positive HIV test result. Continuum (London) 1995; 3(4): 20.
91. SHENTON J. Positively false. Exposing the myths about HIV and AIDS. London: I.B. Tauris; 1998: 277.
92. HODGKINSON N. Science fails the “AIDS test”. In: AIDS: the failure of contemporary science. How a virus that never was deceived the world. London: Fourth Estate, 1996: 232-262.
93. JOHNSON C. Playing Russian roulete in the lab: Can you really trust the AIDS test? New York: The HEAL Bulletin, Special Edition, 1993.
94. JOHNSON C. Is anyone really positive? Continuum (London); April/May 1995.
95. JOHNSON C. Factors known to cause false-Positive HIV antibody test results; Zenger’s San Diego, California, September 1996: 8-9.
96. JOHNSON C. Whose antibodies are they anyway? Continuum (London), September/October 1996; 4(3):4-5.
97. JOHNSON C. The PCR to prove HIV infection. Viral load and why they can’t be used. Continuum (London) 1996; 4:33 -37 and 39.
98. PHILPOTT P & JOHNSON C. Viral load of crap. Reappraising AIDS 1996; 4(10):1-4.
99. GIRALDO RA. Everybody Reacts Positive on the ELISA Test for HIV. Continuum (London) 1999; 5(5): 8-10.
100. WING MG. The molecular basis for a polyspecific antibody. Clin Exp Immunol 1995; 99: 313-315.
101. BARBACID M, BOLOGNESI D, AARONSON SA. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc Nat Acad Sci USA 1980; 77: 1617-1621.
102. SNYDER HW, FLEISSNER E. Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures. Pro Nat Acad Sci USA 1980; 77: 1622-1626.
103. KOVAL TM. Stress-Inducible Processes in Higher Eukaryotic Cells. New York: Plenum Press, 1997: 256.
104. LATCHMAN DS. Stress Proteins. Springer, 1999: 422.
105. MORIMOTO R, TISSIERES A, GEORGOPOULOS C. Stress Proteins in Biology and Medicine. Cold Spring Harbor Laboratory Press 1990: 450.
106. SCHLESINGER MJ, SANTORO MG, GARACI E. Stress Proteins: Induction and Function. Berlin: Springer-Verlag 1990: 123.
107. VAN EDEN W, YOUNG DB. Stress Proteins in Medicine. New York: Marcel Dekker, Inc. 1996: 578.
108. PAPADOPULOS-ELEOPULOS E, TURNER VF, PAPADIMITRIOU JM & CAUSER D. The isolation of HIV: Has it really been achieved? The case against. Continuum (London) 1996; 4(3): S1-S24.
109. PAPADOPULOS-ELEOPULOS E, TURNER V, PAPADIMITRIOU J, et al. Why no whole virus? Continuum (London) 1997; 4(5): 27-30.
110. PHILPOTT P. The isolation question. Does HIV exist? Do HIV tests indicate HIV infection? Here’s why some scientists say no. How an Australian biophysicist and her simple observations have taken center stage among AIDS reappraisers. Reappraising AIDS 1997; 5(6):1-12.
111. DE HARVEN E. Pioneer deplores “HIV” “Maintaining errors is evil” Continuum (London) 1997/8; 5(2): 24.
112. DE HARVEN E. Remarks on methods for retroviral isolation. Continuum (London) 1998; 5(3):20-21.
113. GIRALDO RA. El denominado “virus del sida” o VIH parece que ni siquiera existe. En: Sida y agentes estresantes. Medellín, Colombia: Editorial universidad de Antioquia; 2002: 95-99.
114. GIRALDO RA, ELLNER M, FARBER C, et al. Is it rational to treat or prevent AIDS with toxic antiretroviral drugs in pregnant women, infants, children, and anybody else? The answer is negative. Continuum (London) 1999; 5(6): 38-52.
115. LAURITSEN J. Poison by prescription: the АЗТ story. Нью-Йорк: Asklepios; 1990.
116. ХИРАЛЬДО РА. Стрессовых химических веществ и иммунодефицита. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 24-26.
117. АЛЬ-БАЯТИ МА. Are steroids the real cause of AIDS? Zenger's magazine January 2000 (Issue # 67).
118. EMBID A. Иммунитета и пестицидам. Лекарства дополнительные 1997; Не. 46: 152.
119. ХИРАЛЬДО РА. Стрессовых, физических и иммунодефицита. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 26-27.
120. ХИРАЛЬДО РА. Стрессовые биологических и иммунодефицита. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 27-29.
121. ХИРАЛЬДО РА. Роль тропических болезней на ослабление иммунной системы и в fisiopatogénesis СПИДа. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 37-46.
122. ХИРАЛЬДО РА. Стрессовые психические и иммунодефицита. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 29-31.
123. ХИРАЛЬДО РА. Стрессовые питания и иммунитета. В: СПИД и факторов, вызывающих стресс. Медельин, Колумбия: Издательство Университета Антиокия); 2002: 31-33.
124. RODENAS P. Питания и диетологии. В: врач нудистов считает. Видение природного здоровья и питания. Барселона: Янтарный Океан; 2000: 151-199.
125. RODENAS Стр. забота о себе. Врач нудистов считает. Видение природного здоровья и питания. Барселона: Янтарный Океан; 2000: 203-238.
126. РОДЖЕРС SA. Man does not live by bread alone: диссертации, juicing, cleansing, flushing and укладка феном. В: Wellness against all odds. Syracuse, NY: Prestige Publishing; 1994: 110-144.
127. CAUDILL-SLOSBERG М, FRIEDMAN R. The mind/body model of Health and illness. В: БЕНСОН Н, СТЮАРТ EM. The wellness book: The comprehensive guide to maintaining health and лечения, stress-related illness. Бостон: Birch Lane Press; 1992: 8-14.
128. LOCKIE В, ГЕДДЕС Н. образ жизни и здоровье. В: руководстве полный гомеопатии: принципы и практика от лечения. Буэнос-Айрес: Хавьер Вергара; 1996: 26-29.
129. LANDABURU Е. О материальном благополучии. В: Берегите себя компания! Барселона: Txalaparta; 2001: 13-130.
130. HASS EM. The detox diet. Беркли, Калифорния: Небесный arts; 1996.
131. HASS EM, НОВЕЙ DW. Детоксификация therapy. В: НОВЕЙ DW. Clinician's complete reference to complementary/alternative medicine. St Louis: Mosby; 2000: 702-715.
132. ГОЛЬДБЕРГ B. Детоксификация therapy. По Адресу: Alternative Medicine. The полное руководство. Файф, Вашингтон: Future Medicine Publishing Inc.; 1994: 156-166.
133. ШУЛЬЦ V, ГЕНЗЕЛЬ R, ТАЙЛЕР ВИДИТ. Agents that increase resistance to disease: adaptogens; immune stimulants; botanical antioxidants. В: Rational phytotherapy. A physician guide to herbal medicine. Springer; 1998: 269-273, 273-281, 282-286.
134. ЮАНЬ-KUN L et al. Modulation of immune responses. В: Handbook of probiotics. New York: John Wiley & Sons, Inc.; 1999: 161-177.
135. CAO X. Protective effect of on accupunture immunosuppression. В: NIH Consensus Development Conference on Accupunture, November 3-5, 1997. Bethesda, Уильям Natcher Conference Center. Bethesda: НИЗ Continuing Medical Education. 1997: 129-133.
136. РИД, D. The complete book of Chinese health and healing. Boston: Shambhala Publications, Inc.; 1995: 484.
137. HALLOWELL, M. Herbal healing: a practical introduction to лечебной herbs. Garden City Park, New York: Avery Publishing Group; 1994: 191.
138. F. BATMANGHELIDJ Your body's many после выхода " for water. Fall Church, Вирджиния: Global Health Solutions Inc.; 1997: 181
139. МАЭ А. В плазменный Квинтон. Вода в море нашей внутренней среды. Барселона: Romanya/Вальс, S. A.; 2001: 190.
140. EMBID A. Действие иглоукалывание-прижигание на иммунологические реакции. Дополнительных Лекарственных Средств 1986; Не. 2: 17-22.
141. EMBID A. Массаж, созревания и иммунитета. Лекарства Дополнительные 1991 Году. 27: 78.
142. KOUSMINE C. метод Kousmine. Лекарства Дополнительные 1989; Нет. 17: 19-23.
143. BUCHINGER A. Fasting. В: НОВЕЙ DW. Clinician's complete reference to complementary/alternative medicine. St. Louis: Mosby; 2000: 728-740.
144. EMBID A. El yogur estimula la inmunidad. Medicinas Complementarias 1994; No. 35: 171.
145. TURNER VF. Reducing agents and AIDS - Why are we waiting? Med J Austr 1990; 153:502.
146. HALLIWELL B, CROSS C. Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Arch Intern Med 1991; 151: 29-31.
147. ADAM ES. Antioxidant supplementation in HIV/AIDS. Nurse Practit 1995; 20: 8.
148. BENDICH A. Role of antioxidants in the maintenance of immune function. En: FREI B. Natural antioxidants in human health and disease. (Chapter IV, Immunity and Infection). San Diego: Academic Press; 1994: 447-467.
149. BENDICH A. Antioxidant micronutrients and immunity. En: ROITT IM, DELVES PJ. Encyclopedia of immunology. San Diego: Academic Press; 1992: 151-153..
150. FAWZI WW, HUNTER DJ. Vitamins in HIV disease progression and vertical transmission. Epidemiology 1998; 9: 457-466.
151. SEMBA RD. Vitamin A, immunity, and infection. Clin Inf Dis 1994; 19: 489-499.
152. SEMBA RD. The role of vitamin A and related retinoids in immune function. Nutr Rev 1998; 56: S38-S48.
153. WARD BJ et al. Vitamin A status in HIV infection. Nutr Res 1993; 13: 157-166.
154. SEMBA RD et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993; 153: 2149-2154.
155. SEMBA RD et al. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. JID 1995; 171: 1196-1202.
156. FAWZI WW et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J 1999; 18: 127-133.
157. COUTSOUDIS A et al. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995; 85: 1076-1081.
158. SEMBA RD et al. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. JIF 1994; 171: 1196-1202.
159. SEMBA RD. Vitamin A and human immunodeficiency virus infection. Proc Nutr Soc 1997; 56: 1-11.
160. KARTER DL et al. Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study. J AIDS Hum Retrov irol 1995; 8: 199-203.
161. LANDESMAN S. Vitamin A relationships to mortality in HIV disease and effects on HIV infection: recent and late breaking studies. Presented at forum, Lawton Chiles International House, National Institutes of Health, Bethesda, MD, May 16, 1996.
162. TANG AM et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613-620.
163. COODLEY GO. Beta-carotene therapy in human immunodeficiency virus infection (Abstract). Clin Res 1991; 29: 634A.
164. COODLEY GO et al. Beta-carotene in HIV infection. JAIDS 1993; 272-276.
165. COODLEY et al. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996; 10: 967-973.
166. GAREWAL HS et al. A preliminary trial of beta-carotene in subjects infected with the human immunodeficiency virus. J Nutr 1992; 122: 728-732.
167. ULLRICH R et al. Serum carotene deficiency in HIV-1 infected patients. AIDS 1994; 8: 661-665.
168. LOYA S et al. The carotenoid halocynthiaxanthin: a novel inhibitor of the reverse transcriptase of human immunodeficiency viruses type 1 and type 2. Arch Biochem Biophys 1992; 293: 208-212.
169. WATSON RR et al. Enhanced survival by vitamin A supplentation during retrovirus infection causing murine AIDS. Life Sci 1988; 43: 13-18.
170. YANG Y et al. Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells. Proc Natl Acad Sci USA 1995; 92: 3051-3055.
171. WANG Y et al. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J Nutr 1994; 124: 2024-2032.
172. WANG Y et al. Modulation of immune function and cytokine production by various levels of vitamin E supplementation during murine AIDS. Immunopharmacol 1995; 29: 225-233.
173. CATHART R. Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS). Med Hypothesis 1984: 14: 423.
174. HARAKEH S, JARIWALLA RJ, PAULING L. Suppression of human immunodeficiency virus replication by ascarbate in chronically and acutely infected cell. Proc Natl Acad Sci U.S.A. 1990; 87: 7245-7249.
175. HARAKEH S et al. Mechanistic aspects of ascarbate inhibition of human immunodeficiency virus. Chemico-biological Interactions 1994; 91: 207-215.
176. MCDONALD KS et al. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 2001; 15: 635-639.
177. MEHENDALE SM et al. Low carotenoid concentration and the risk of HIV seroconversion in Pune, India. JAIDS 2001; 26: 352-359.
178. MOORE PS et al. Role of nutritional status and weight loss in HIV seroconversion among Rwandan women. JAIDS 1993; 6: 611-616.
179. GREENBERG BL et al. Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS 1997; 11: 325-332.
180. SEMBA RD et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-1597.
181. FAWZI WW et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. JAIDS 2000; 23: 246-254.
182. PHUAPRADIT W et al. Serum vitamin A and betha-carotene levels in pregnant women infected with human immunodeficiency virus-1. Ostet Gynecol 1996; 87: 564-567.
183. SEMBA RD et al. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Inf Dis 1995; 21: 966-972.
184. COUTSOUDIS A et al. Ramdomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 1999; 13: 1517-1524.
185. LAN Y et al. Carotenoid status of pregnant women with and without HIV infection in Malawi. East Afr Med J 1999; 76: 133-137.
186. FAWZI WW et al. Randomized trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998; 351: 1477-1482.
187. SEMBA RD et al. Maternal vitamin A deficiency and child growth failure during human immunodeficiency virus infection. JAIDS 1997; 14: 219-222.
188. COUTSOUDIS A et al. Effect of vitamin A supplementation on viral load in HIV-1 infected pregnant women. JAIDS 1997; 15: 86-87.
189. JOHN GC et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. JID 1997; 175: 57-62.
190. MOSTAD SB et al. Hormonal concentration, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from cervix and vagina. Lancet 1997; 350: 922-927.
191. NDUATI RW et al. Human immunodeficieny virus type-1 infected cells in breast milk: association with immunosuppression and vitamin A deficiency. JID 1995; 172: 1461-1468.
192. РОТМАН KJ et al. Teratogenicity of high vitamin В intake. NEJM 1995; 333: 1369-1373.
193. BOUMPAS DT et al. Interleukins interferons and. В: RICH RR. Clinical immunology, principles and practice. Chapter F, Immune Modulation. London: Mosby; 2001: 115.1-115.12.
194. BYRN РА, РОБЕРТС MR. Cellular therapy подходы to the treatment of AIDS. В: MORSTYN G, W. SHERIDAN Cell Therapy: Stem cell transplantation, Джин therapy, and cellular immunotherapy. Cambridge: Cambridge University Press; 1996: 414-428.
195. МУР БОЛЬШЕ. Colony-stimulating factor. В: RICH RR. Clinical immunology, principles and practice. Chapter F Immune Modulation. London: Mosby; 2001: 114.1-114.13.
196. EHRENPREIS ED et al. Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 1994; 39: 2159-2162.
197. ТАН AM et al. Low serum vitamin B12 Chemistry are associated with faster human bdy virus type 1 (HIV-1) disease progression. J Nutr 1997; 127: 345-351.
198. BAUM MK et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. JAIDS 1991; 4: 1122-1132.
199. ХАУГ C et al. Субнормальных serum concentration of 1,25 -vitamin D in human bdy infection: correlation with degree of immune deficiency and survival. JID 1994; 169: 889-893.
200. J. LIEB Lithium and immune function. Med Hypothesis 1987 Года; 23: 73-93.
201. SHENKMAN Л, BORKOWSKY ВТ, SHOPSIN B. Lithium as an immunologic adjuvant. Med Hypothesis 1980; 6: 1-6.
202. ФЕНТОН М, SILVERMAN E. Medical nutritional therapy for human bdy virus (HIV) infection and acquired bdy syndrome (AIDS). В: MAHAN K, ESCOTT-STUMP S. Краузе ’s Food, nutrition and diet therapy. Philadelphia: W. B. Saunders Company; 2000: 889-911.
203. ROMEYN M. Nutrition and HIV. Сан-Франциско: Jossey-Бас Publishers; 1995: 353.
204. ХИКСОН JF. Diet and nutrition for optimal immune function. В: BAHL SM, ХИКСОН JF. Пищевая care for HIV-positive persons: a manual for individuals and their caregivers. Boca Raton: CRC Press; 1995: 1-36.
205. PASSI S, LUCA C. Диетической advice for bdy. Континуум (London) 1998-1999; 5(5): 43-52.
206. ФЕРГЮСОН В, ГРИФФИН GE. Nutrition and the immune system. В: GARROW JS, JAMES WPT, RALPH A. Human nutrition and dietetics. Edinburgh: Churchill Livingstone; 2000: 747-766.
207. LABE РФ. Nutrition support. Clinics in Laboratory Medicine, 1993; 13: 323-530.
208. BEISEL WR. Single nutrients and immunity. Am J Clin Nutr 1982; 35: 417-468.
209. BEISEL WR. The history of nutritional immunology. J Nutr Immunol 1991; 1: 62-78.
210. ЧАНДРА РК. Micronutrients and immune functions, an overview. Ann NY Acad Sci 1990; 587: 9-16.
211. EMBID A. Иммунитет усиливается рост по micronutrients. Дополнительных Лекарственных Средств 1994 Году; Не. 35: 172.
212. EMBID А. Иммунотерапия в дозах бесконечно малыми. Дополнительных Лекарственных Средств 1995; Не. 38: 170.
213. ТАЙЛЕР ВИДИТ, ROBBERS JE. Тайлер ’s Herbs of choice the therapeutic use of phytomedicinals. New York: Pharmaceutical Products Press; 1999: 287.
214. АТКИНС RC. Immune-enhancing herbs. Infection это далеко не все. В: д-Р Atkins’ vita-nutrient solution. Nature's answer to drugs. New York: Fireside; 1999: 294-296 и 297-299.
215. ФИШМАН RHB. Antioxidants and phytotherapy. Lancet 1994: 344: 1356.
216. ГРИНСПЕН HC. The role of oxidative oxygen species, antioxidants and phytopharmaceuticals in human bdy вирусов activity. Med Hypothesis 1993; 40: 85.
217. ГРИНСПЕН HC, AROUMA O. Oxidative stress and апоптоз in HIV infection: a role for plant-derived метаболиты with synergistic газов $ + хроматографи activity. Immunol Today 1994; 15: 209.
218. ГРИНСПЕН HC, AROUMA O. Could oxidative stress initiate programmed cell death in HIV infection? A role for plant derived метаболиты having synergistic газов $ + хроматографи activity. Chemico-Biological Interactions 1994; 91: 187-197.
219. EMBID A. пыли, защита нефрит, один рецепт классический для того, чтобы стимулировать иммунитет. Дополнительных Лекарственных Средств 1993; Не. 32: 73-87.
220. EMBID A. Astragalus un biomodulador del sistema inmunitario. Medicinas Complementarias 1994; No. 35: 67-71.
221. EMBID A. Más plantas para estimular la inmunidad. Medicinas Complementarias 1994; No. 36: 174.
222. EMBID A. Uña de gato para el sida. Medicinas Complementarias 1994; No. 36: 174.
223. MANN J, HOY J, MILLS J. Management of the HIV-infected patient. Cambridge: Cambridge University Press; 1996: 437.
224. BARLETT JG, FINKBEINER AK. The guide to living with HIV infection. Johns Hopkins AIDS Clinic. Baltimore: The Johns Hopkins University Press; 1996: 295.
225. DOLIN R, MASUR H, SAAG MS. AIDS therapy. New York: Churchill Livingstone; 1999: 864.
226. POWDERLY WG. Manual of HIV therapeutics. Philadelphia: Lippincott Williams & Wilkins; 2001: 274.
227. CROWES S, HOY J, MILLS J. Management of the HIV-infected patient. London: Martin Dunitz; 2002: 630.
228. SILVERMAN WA. Informing and consenting. En: Where’s the evidence? Controversies in modern medicine. Oxford: Oxford University PRESS; 1998: 78-84.
229. O’MARA P. Life, liberty, and informed consent. Mothering (September-October) 1998; (90): 6-9.
230. GOSTIN LO, LAZZARINI Z. International human rights law in the AIDS pandemic. En: Human rights and public health in the AIDS pandemic. Nueva York: Oxford university Press; 1997: 1-42.
231. TANG AM et al. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. JAIDS 2000; 23: 321-326.
BIBLIOGRAFIA
a. GIRALDO R. Tratamiento y prevención del sida como síndrome tóxico-nutricional. En: SIDA y agentes estresantes. Medellín, Colombia: Editorial Universidad de Antioquia. 2002: 112-115.
b. RODENAS P. ¿Cuál es el tratamiento del sida? En: El médico naturista opina: Una vision natural de la salud y la alimentación. Barcelona: Océano Grupo Editorial, S.A. 2000: 109-115.
c. EMBID A. Estimular las defensas de otra forma. Tratamientos de los síndromes de inmunodeficiencia. Madrid: Medicinas complementarias 1992: 214.
d. EMBID A. Enciclopedia de medicina functional y oligoterapia. Madrid: Medicinas complementarias; 1992.
e. NULL G. Alternative treatments. En: AIDS: A second opinion. New York: Seven Stories Press; 2002: 487-581.
f. GOLDBERG B. AIDS. En: Alternative Medicine. The definitive guide. Fife, Washington: Future Medicine Publishing Inc.; 1994: 494-509.
g. АБРАМС ДИ. Alternative therapies. В: САНДЕ МА, VOLBERDING PA. The medical management of AIDS. 6a ed. Филадельфия: W. B. Saunders Company; 1999: 601-612.
h. BADGLEY L. Healing AIDS naturally: natural therapies for the immune system. Фостер-Сити, Калифорния: Human energy Press; 1990: 410.
i. BYRNES S. Overcoming AIDS with natural medicine: A program for recovery. Revised, 2nd edition. Гонолулу, Гавайи: Ecclesia Life Mana; 2001: 183.
j. REILLO M. AIDS under pressure: hyperbaric medicine in the management of HIV disease. Сиэтл: Gogrefe & Huber Publishers; 1997: 124.
k. ФЕНТОН М, SILVERMAN E. Medical nutrition therapy for human bdy virus (HIV) infection and acquired bdy syndrome (AIDS). В: MAHAN LK, ESCOTT-Stump S. Food, nutrition & diet therapy. Philadelphia: W. B. Saunders Company; 2000: 889-911.
l. MAHAN LK, ESCOTT-STUMP S. Medical nutrition therapy for human bdy virus (HIV) infection and acquired bdy syndrome (AIDS). В: Krause's food, nutrition and diet therapy. Philadelphia: W. B. Saunders; 2000: 889-911.
м. ROMEYN M. Nutrition and HIV. San Francisco: Jossey-Bass Publishers; 1995: 355.
n. BAHL SM, ХИКСОН JF. Nutritional care for HIV-positive persons: a manual for individuals and their caregivers. Boca Raton: CRC Press; 1995: 190.
или. WATSON RR. Nutrition and AIDS. 2a ed. Boca Raton: CRC press; 2001: 231.
p. BEISEL WR. AIDS. В: GERSHWIN МНЕ, JB GERMAN, KEEN CL. Nutrition and immunology: principles and practice. Totowa: Human Press; 2000: 389-401.
q. GERRIOR J, WANKE C. Nutrition and bdy syndromes. В: COULSTON AM, ROCK CL, MONSEN ER. Nutrition in the prevention and treatment of disease. San Diego: Academic Press; 2001: 741-750.
r. ZHANG Z, INSERRA PF, WATSON RR. Antioxidants and AIDS. В: GAREWAL HS. Antioxidants and disease prevention. Boca Raton: CRC Press; 1997: 31-43.
s. BENDICH A. Role of antioxidants in the maintenance of immune system. В: FREI B. Natural antioxidants in human health and disease. (Chapter IV Immunity and Infection). San Diego: Academic Press; 1994: 447-467.
t. GAREWAL HS. Antioxidants and disease prevention. Boca Raton: CRC Press; 1997: 186.
или. SIES H. Oxidative stress: oxidants and antioxidants. London: Academic Press; 1991: 507.
v. FREI B. Natural antioxidants in human health and disease. Сан Diego: Academic Press; 1994: 588.
Вт. BRIGTHOPE I. The AIDS fighters. New Canaan, Conneccticut: Кита Publishing; 1988: 184.
x. ПОМОЛЧИТЕ М. Восстание AIDS. Нью-Йорк: Харпер Коллинз; 1990.
и. CHAITOW L. Candida Albican, could yeast be your problem? Expanded and revised edition. Рочестер, Вермонт: Healing Arts Press; 1998:1522.
z. CHAITOW L. The natural way: HIV & AIDS. Your guide to complementary therapies, alternative techniques and conventional treatments. Shaftesbury, UK: Element Books Limited; 1999 г: 150.